Nicotinamide Adenine Dinucleotide Market

ID: MRFR/CnM/28506-HCR

111 Pages

Chitranshi Jaiswal

September 2025

Nicotinamide Adenine Dinucleotide Market Research Report By Type (Oral Supplements, Injectable Supplements, Topical Creams, Other Forms), By Application (Energy Metabolism, Antioxidant Defense, Cellular Repair, Cognitive Enhancement), By Distribution Channel (Retail Pharmacies, Online Retailers, Fitness Centers, Medical Clinics), By Dosage (Low Dosage (Up to 100mg), Medium Dosage (100-500mg), High Dosage (500mg+), Customized Dosage), By Target Audience (Middle-Aged Adults, Elderly Population, Health-Conscious Individuals, Athletes, Healthcar...

Nicotinamide Adenine Dinucleotide Market Infographic

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Infographic

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Nicotinamide Adenine Dinucleotide Market Summary

The Global Nicotinamide Adenine Dinucleotide Market is projected to experience substantial growth from 3.51 USD Billion in 2024 to 10.8 USD Billion by 2035.

Key Market Trends & Highlights

Nicotinamide Adenine Dinucleotide Key Trends and Highlights

The market is expected to grow at a compound annual growth rate (CAGR) of 10.76% from 2025 to 2035.
By 2035, the market valuation is anticipated to reach 10.8 USD Billion, indicating robust expansion.
In 2024, the market is valued at 3.51 USD Billion, reflecting a strong foundation for future growth.
Growing adoption of Nicotinamide Adenine Dinucleotide supplements due to increasing awareness of health benefits is a major market driver.

Nicotinamide Adenine Dinucleotide Market

CAGR

10.76%

Market Size & Forecast

2024 Market Size	3.51 (USD Billion)
2035 Market Size	10.8 (USD Billion)
CAGR (2025-2035)	10.76%

Major Players

Sigma-Aldrich, Cayman Chemical, Hampton Research, Abcam, BioVision, Lonza, Mitsubishi Gas Chemical Company, Niagen, Vitabiotics, Kyowa Hakko Kirin, BioTechne, Alfa Aesar, InvivoGen, Tocris, DSM

Nicotinamide Adenine Dinucleotide Market Trends

Key market drivers include the rising prevalence of age-related diseases, the increasing adoption of personalized medicine, and the growing interest in anti-aging supplements.

Opportunities to be explored include the development of new delivery systems, the expansion into emerging markets, and the formulation of combination products.

Recent trends have shown an increased focus on sustainability, with a growing demand for plant-based and vegan options. The market is also being driven by the rising popularity of online retail channels, which offer convenience and a wider selection of products.

Source Primary Research, Secondary Research, Market Research Future Database and Analyst Review

The increasing recognition of nicotinamide adenine dinucleotide's role in cellular metabolism and aging processes suggests a burgeoning interest in its applications across various sectors, including pharmaceuticals and nutraceuticals.

National Institutes of Health (NIH)

Nicotinamide Adenine Dinucleotide Market Drivers

Rising Demand for Anti-Aging Products

The Global Nicotinamide Adenine Dinucleotide Market Industry experiences a notable surge in demand for anti-aging products. As consumers increasingly prioritize skin health and longevity, NAD+ supplements and topical applications gain traction. This trend is underscored by the projected market value of 3.51 USD Billion in 2024, reflecting a growing awareness of NAD+ benefits in cellular repair and energy metabolism. The anti-aging segment is likely to dominate, driven by the aging population and the desire for youthful skin. Consequently, manufacturers are innovating formulations to enhance bioavailability, thereby expanding their product offerings in the Global Nicotinamide Adenine Dinucleotide Market Industry.

Market Segment Insights

Nicotinamide Adenine Dinucleotide Market Segment Insights

Nicotinamide Adenine Dinucleotide Market Type Insights

The Nicotinamide Adenine Dinucleotide Market is segmented into Oral Supplements, Injectable Supplements, Topical Creams, and Other Forms based on Type. Oral Supplements held the largest market share in 2023, accounting for nearly half of the Nicotinamide Adenine Dinucleotide Market revenue.

The segment's dominance can be attributed to the ease of administration and widespread availability of oral supplements. Injectable Supplements are expected to register the highest CAGR during the forecast period, owing to the increasing adoption of injectable NAD+ therapies for conditions like aging and neurodegenerative diseases.

Nicotinamide Adenine Dinucleotide Market Application Insights

The 'Energy Metabolism' segment held the largest market share of 37.4% in 2023 and is projected to reach USD 2.7 billion by 2032. Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in all living cells and plays a critical role in cellular energy production. NAD+ is involved in the electron transport chain, which generates ATP, the energy currency of cells.

As the population ages, the demand for products that support energy metabolism is expected to increase. The 'Antioxidant Defense' segment is expected to grow at a CAGR of 11.2% during the forecast period.

Nicotinamide Adenine Dinucleotide Market Distribution Channel Insights

The distribution channel segment plays a crucial role in the Nicotinamide Adenine Dinucleotide Market. Retail pharmacies hold a significant share of the market, driven by factors such as the convenience and accessibility they offer to customers. Online retailers have also gained prominence, particularly during the COVID-19 pandemic, due to the shift towards online shopping.

Fitness centers and medical clinics represent growing distribution channels for Nicotinamide Adenine Dinucleotide. The increasing prevalence of chronic diseases, rising awareness about health and wellness, and the growing popularity of fitness supplements are key factors driving market growth.

Nicotinamide Adenine Dinucleotide Market Dosage Insights

The Nicotinamide Adenine Dinucleotide Market segmentation by Dosage comprises Low Dosage (Up to 100mg), Medium Dosage (100-500mg), High Dosage (500mg+), and Customized Dosage. Among these, the Medium Dosage segment held the largest market share in 2023, accounting for around 40% of the Nicotinamide Adenine Dinucleotide Market revenue.

The segment's dominance can be attributed to the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes, which require medium doses of Nicotinamide Adenine Dinucleotide for effective treatment.

Nicotinamide Adenine Dinucleotide Market Target Audience Insights

The target audience for the Nicotinamide Adenine Dinucleotide Market consists of various segments with distinct needs and preferences.

Middle-aged adults, representing a significant portion of the population, are increasingly seeking health supplements to maintain their well-being. The elderly population, with growing concerns about age-related health issues, is another key target audience.

Get more detailed insights about Nicotinamide Adenine Dinucleotide Market Research Report — Global Forecast till 2034

Request Free Sample

Regional Insights

The regional segmentation of the Nicotinamide Adenine Dinucleotide Market offers valuable insights into the market's geographical distribution and growth dynamics. North America dominated the market in 2023, accounting for a significant share of the Nicotinamide Adenine Dinucleotide Market revenue.

The region's dominance can be attributed to the presence of a large consumer base, well-established healthcare infrastructure, and increasing awareness about the benefits of nicotinamide adenine dinucleotide. Europe is projected to follow North America in terms of market share, driven by growing demand from the pharmaceutical and cosmetic industries.

The Asia-Pacific region is anticipated to witness the fastest growth rate during the forecast period, owing to the rising disposable income, increasing healthcare expenditure, and expanding population. South America and the Middle East and Africa are also expected to contribute to the Nicotinamide Adenine Dinucleotide Market growth, albeit at a slower pace.

Source Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Key Players and Competitive Insights

Major players in the Nicotinamide Adenine Dinucleotide Market industry are constantly looking for ways to improve their products and gain a competitive edge. Leading Nicotinamide Adenine Dinucleotide Market players are also focusing on expanding their reach into new markets and developing innovative products to meet the needs of changing consumer preferences.

The Nicotinamide Adenine Dinucleotide Market industry is highly fragmented, with a large number of small and medium-sized players competing for market share. However, a few large players dominate the market, such as Sigma-Aldrich, Merck KGaA, and Bio-Techne. These companies have a strong presence in both developed and emerging markets and offer a wide range of Nicotinamide Adenine Dinucleotide products.

A leading company in the Nicotinamide Adenine Dinucleotide Market, Sigma-Aldrich, is a leader in the life science industry. The company offers a wide range of products and services to researchers, including Nicotinamide Adenine Dinucleotide.

Sigma-Aldrich has a strong focus on innovation and is constantly developing new products to meet the needs of its customers. The company has a presence and sells its products in over 100 countries.

A competitor company in the Nicotinamide Adenine Dinucleotide Market, Merck KGaA, is a pharmaceutical and chemical company. The company offers a wide range of products and services, including Nicotinamide Adenine Dinucleotide.

Merck KGaA has a strong focus on research and development and is constantly developing new products to meet the needs of its customers. The company has a presence and sells its products in over 100 countries.

Key Companies in the Nicotinamide Adenine Dinucleotide Market market include

Industry Developments

The rising demand for NAD+ supplements as anti-aging agents and the growing prevalence of age-related diseases are key factors driving market growth. Additionally, increasing research on the role of NAD+ in cellular processes and its potential therapeutic applications is expected to further boost market demand. Recent news highlights include

In March 2023, ChromaDex announced the launch of a new NAD+ supplement, Tru Niagen Pro, which combines NAD+ with other nutrients for enhanced absorption and bioavailability.

In February 2023, Elysium Health secured USD 50 million in funding to expand its research and development of NAD+ supplements and other longevity-focused products.

In January 2023, the University of California, San Francisco, published a study suggesting that NAD+ supplements may improve cognitive function in older adults.

Future Outlook

Nicotinamide Adenine Dinucleotide Market Future Outlook

The Global Nicotinamide Adenine Dinucleotide Market is projected to grow at a 10.76% CAGR from 2024 to 2035, driven by rising health awareness and advancements in biotechnology.

New opportunities lie in:

Develop innovative NAD+ supplements targeting aging populations. Invest in research for NAD+ applications in metabolic disorders. Expand distribution channels in emerging markets to capture new customer segments.

By 2035, the market is expected to demonstrate robust growth, positioning itself as a leader in health and wellness solutions.

Market Segmentation

Nicotinamide Adenine Dinucleotide Market Type Outlook

Nicotinamide Adenine Dinucleotide Market Dosage Outlook

Nicotinamide Adenine Dinucleotide Market Regional Outlook

Nicotinamide Adenine Dinucleotide Market Application Outlook

Nicotinamide Adenine Dinucleotide Market Target Audience Outlook

Nicotinamide Adenine Dinucleotide Market Distribution Channel Outlook

Report Scope

Report Attribute/Metric	Details
Market Size 2024	3.51(USD Billion)
Market Size 2025	3.89(USD Billion)
Market Size 2034	9.78(USD Billion)
Compound Annual Growth Rate (CAGR)	10.80% (2025 - 2034)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2034
Historical Data	2020 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Sigma-Aldrich, Cayman Chemical, Hampton Research, Abcam, BioVision, Lonza, Mitsubishi Gas Chemical Company, Niagen, Vitabiotics, Kyowa Hakko Kirin, BioTechne, Alfa Aesar, InvivoGen, Tocris, DSM
Segments Covered	Type, Application, Distribution Channel, Dosage, Target Audience, Regional
Key Market Opportunities	1 Growing Demand for Anti-Aging Supplements 2 Rising Prevalence of Age-Related Diseases 3 Increasing Adoption in Nutraceutical Products 4 Expansion into Emerging Markets 5 Technological Advancements in Delivery Systems
Key Market Dynamics	Increasing health consciousness Rising prevalence of chronic diseases Technological advancements Growing awareness of NAD supplements Expanding applications in cosmetics and antiaging
Countries Covered	North America, Europe, APAC, South America, MEA

FAQs

What was the market size of the Nicotinamide Adenine Dinucleotide market in 2024?

The Nicotinamide Adenine Dinucleotide market reached USD 3.51 billion in 2024.

What is the projected CAGR of the Nicotinamide Adenine Dinucleotide market from 2025 to 2034?

The Nicotinamide Adenine Dinucleotide market is projected to grow at a CAGR of 10.80% from 2025 to 2034.

Which region is expected to hold the largest market share in the Nicotinamide Adenine Dinucleotide market in 2032?

North America is expected to hold the largest market share in the Nicotinamide Adenine Dinucleotide market in 2032.

What are the key applications of Nicotinamide Adenine Dinucleotide?

Key applications of Nicotinamide Adenine Dinucleotide include dietary supplements, food and beverages, and pharmaceuticals.

Who are the major competitors in the Nicotinamide Adenine Dinucleotide market?

Major competitors in the Nicotinamide Adenine Dinucleotide market include Niagen, Chromadex, and Bio-Tech Pharmacal.

What is the expected market size of the Nicotinamide Adenine Dinucleotide market in 2032?

The Nicotinamide Adenine Dinucleotide market is expected to reach USD 7.2 billion in 2032.

What are the factors driving the growth of the Nicotinamide Adenine Dinucleotide market?

Factors driving the growth of the Nicotinamide Adenine Dinucleotide market include increasing awareness of the health benefits of NAD+, rising demand for dietary supplements, and growing applications in the food and beverage industry.

What are the challenges facing the Nicotinamide Adenine Dinucleotide market?

Challenges facing the Nicotinamide Adenine Dinucleotide market include regulatory hurdles, competition from other NAD+ precursors, and concerns about the safety and efficacy of NAD+ supplements.

What are the opportunities for growth in the Nicotinamide Adenine Dinucleotide market?

Opportunities for growth in the Nicotinamide Adenine Dinucleotide market include expanding applications in the pharmaceutical industry, increasing demand for NAD+ supplements in emerging markets, and growing interest in NAD+ as a potential treatment for age-related diseases.

What are the key trends in the Nicotinamide Adenine Dinucleotide market?

Key trends in the Nicotinamide Adenine Dinucleotide market include the development of new NAD+ delivery systems, the growing popularity of NAD+ IV therapy, and increasing research on the health benefits of NAD+.

Nicotinamide Adenine Dinucleotide Market Research Report — Global Forecast till 2034 Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027